RFK Jr. to face questioning in House, Senate
Health Care Newsletter
RFK Jr. to face questioning in House, Senate
by Joseph Choi and Nathaniel Weixel - 04/15/26 6:12 PM ET
Link copied
by Joseph Choi and Nathaniel Weixel - 04/15/26 6:12 PM ET
Link copied
96
- Presented by the Coalition to Strengthen America’s Healthcare
{beacon}
View Online
Health Care
Health Care
PRESENTED BY
The Big Story
Kennedy set for Hill visits
Health Secretary Robert F. Kennedy Jr. kicks off a whirlwind of congressional hearings on Thursday, testifying before the House Ways and Means Committee in the morning and the House Appropriations health subcommittee in the afternoon.
© Greg Nash
He will appear before an Education and Workforce subcommittee Friday. Next week, Kennedy is set to testify in a Senate Appropriations subcommittee, the Senate HELP Committee and the Senate Finance Committee.
Thursday will mark Kennedy’s first appearance on Capitol Hill since a highly contentious Senate Finance Committee hearing last September, where Democrats and even some Republicans grilled him about his vaccine views and leadership shakeups at the Centers for Disease Control and Prevention.
Kennedy’s hearings are about the HHS budget and he’ll likely face sharp questions from Democrats about the administration’s priorities: the White House proposal would cut HHS funding by 12.5 percent relative to what Congress approved for the current fiscal year, including deep reductions to the National Institutes of Health and the creation of a new Administration for a Healthy America (AHA).
The White House proposed a similar budget last year, but Congress ultimately allotted the agency $33 billion more than what the administration requested, with no funding for the AHA.
Kennedy’s written testimony provided in advance of his afternoon hearing will highlight the administration’s wins that are part of the Make America Healthy Again movement, including revamped dietary guidelines, working with companies to eliminate artificial food dyes, and an ongoing review of baby formula.
Kennedy will also talk about the administration’s drug pricing efforts and urge Congress to codify Trump’s Most Favored Nation deals.
Notably absent is any formal reference to vaccines, as the White House tries to navigate a political tightrope ahead of the midterm elections. Kennedy and his vaccine-skeptical allies have upended federal vaccine policy and made sweeping changes to the childhood vaccine schedule this year, moves that could be a liability for Republicans in November.
 
Welcome to The Hill’s Health Care newsletter, we’re Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health.
 
Did someone forward you this newsletter? Subscribe here.
 
Essential Reads
How policy will be impacting the health care sector this week and beyond:
 
Maryland separates from RFK Jr. vaccine guidance
Legislation signed by Maryland Gov. Wes Moore (D) would de-couple the state from following the recommendations of a federal vaccine advisory panel that was remade by Health Secretary Robert F. Kennedy Jr. The Vax Act, signed by Gov. Wes Moore (D) Tuesday, directs the state’s health secretary to issue official recommendations for immunizations, screening and preventive …
Full Story
 
Protect Our Care publishes scathing report of Kennedy’s tenure ahead of congressional hearing marathon
The progressive health care advocacy group Protect Our Care is releasing a highly critical review of Health and Human Services Secretary Robert F. Kennedy Jr.’s first 14 months in office ahead of a marathon series of hearings he will have in the House and Senate this month to defend President Trump’s budget request. In the report titled “Robert F. Kennedy Jr. vs. Public Health,” shown first to The Hill, …
Full Story
 
FDA to weigh lifting restrictions on some MAHA-favored peptides
The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide injections that are currently restricted due to safety concerns. The agency on Wednesday said it is convening a meeting of an outside advisory panel in July to discuss whether to allow compounding pharmacies to manufacture peptides for ulcerative colitis, wound healing, obesity …
Full Story
 
 
 
CONTENT FROM OUR SPONSOR
Rising premiums are outpacing inflation
When insurer practices drive up costs, families feel it in their monthly premiums. Without reform, healthcare costs could continue rising faster than inflation—putting care further out of reach for millions of Americans. Learn more
 
 
In Other News
Branch out with a different read from The Hill:
Judge rules that HUD effort to change criteria for homeless funding is unlawful
A federal judge in Rhode Island ruled on Tues